Published February 19, 2025 | Version v1

Beyond Joint Pain: The Hidden Link Between RA and Thyroid Dysfunction

Description

RA and thyroid dysfunction are two prevalent autoimmune diseases that often occur together. While RA is mainly characterized by chronic inflammation of the joints, thyroid dysfunction is a broad category of conditions that includes hypothyroidism, hyperthyroidism, and autoimmune thyroid diseases such as Hashimoto's thyroiditis and Graves' disease. Currently, evidence is emerging for a strong bidirectional association between RA and thyroid dysfunction, with common genetic, immunological, and environmental factors in their pathogenesis playing the key role. In this review, the complex relationship of RA with thyroid dysfunction regarding the underlying mechanisms, clinical implications, and potential treatments is discussed. This submerged relationship thus guides the improvement in the quality of life of patients with co-existing RA and thyroid disorders.

Files

Files (26.7 kB)

Name Size
md5:7bc6fd67e0931d20752a1c84b8e727c5
26.7 kB Download

Additional details

References

  • 1. Smith, J. A., & Jones, B. C. (2020). The genetic basis of autoimmune diseases: Insights from genome-wide association studies. Nature Reviews Genetics, 21(5), 289-304.
  • 2. Brown, D. E., & Green, F. G. (2019). Immunological mechanisms in Rheumatoid Arthritis and thyroid dysfunction: A comprehensive review. Journal of Autoimmunity, 98, 1-12.
  • 3. Taylor, P. C., & Williams, R. O. (2021). Targeted therapies in Rheumatoid Arthritis: Current status and future directions. The Lancet Rheumatology, 3(2), e100-e110.
  • 4. Davies, T. F., & Latif, R. (2018). Graves' disease: Pathogenesis and emerging therapies. Endocrine Reviews, 39(5), 623-646
  • 5. McInnes, I. B., & Schett, G. (2017). The pathogenesis of Rheumatoid Arthritis. New England Journal of Medicine, 375(23), 2225-2236.
  • 6. Firestein, G. S., & McInnes
  • 7. Smolen, J. S., Aletaha, D., & McInnes, I. B. (2016). Rheumatoid arthritis. The Lancet, 388(10055), 2023–2038. DOI: 10.1016/S0140-6736(16)30173-8
  • 8. Antonelli, A., Ferrari, S. M., Corrado, A., Di Domenicantonio, A., & Fallahi, P. (2015). Autoimmune thyroid disorders. Autoimmunity Reviews, 14(2), 174–180. DOI: 10.1016/j.autrev.2014.10.016
  • Gregersen, P. K., Silver, J., & Winchester, R. J. (1987). The shared epitope hypothesis: An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis & Rheumatism, 30(11), 1205–1213. DOI: 10.1002/art.1780301102
  • 10. Begovich, A. B., et al. (2004). A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. The American Journal of Human Genetics, 75(2), 330–337. DOI: 10.1086/422827
  • Gough, S. C., et al. (2005). The CTLA4 gene region and susceptibility to autoimmune thyroid disease. Genes & Immunity, 6(7), 584–590. DOI: 10.1038/sj.gene.6364251
  • 12. Caturegli, P., De Remigis, A., & Rose, N. R. (2014). Hashimoto thyroiditis: Clinical and diagnostic criteria. Autoimmunity Reviews, 13(4-5), 391–397. DOI: 10.1016/j.autrev.2014.01.007
  • 13. Okada, Y., et al. (2014). Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature, 506(7488), 376–381. DOI: 10.1038/nature12873
  • Bettelli, E., et al. (2007). TH17 cells in human disease. Immunological Reviews, 226, 87–102. DOI: 10.1111/j.1600-065X.2007.00529.x
  • 15. Choy, E. H., & Panayi, G. S. (2001). Cytokine pathways and joint inflammation in rheumatoid arthritis. New England Journal of Medicine, 344(12), 907–916. DOI: 10.1056/NEJM200103223441206